Pnc Financial Services Group, Inc. Astrazeneca PLC Transaction History

Pnc Financial Services Group, Inc.

$156 Billion
Q3 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 238,228 shares of AZN stock, worth $16 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

238,228

Previous 233,648 1.96%

Holding current value

$16 Million

Previous $18.2 Million 1.87%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$76.67 - $87.62 $351,148 - $401,299	4,580 Added 1.96%	238,228 $18.6 Million
Q2 2024 Aug 09, 2024	BUY	$66.81 - $80.83 $60,797 - $73,555	910 Added 0.39%	233,648 $18.2 Million
Q1 2024 May 10, 2024	SELL	$61.03 - $69.57 $97,831 - $111,520	-1,603 Reduced 0.68%	232,738 $15.8 Million
Q4 2023 Feb 09, 2024	BUY	$61.89 - $69.28 $199,595 - $223,428	3,225 Added 1.4%	234,341 $15.8 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $1.76 Million - $1.95 Million	-27,187 Reduced 10.53%	231,116 $15.7 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $88,016 - $95,444	1,259 Added 0.49%	258,303 $18.5 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $30,312 - $34,368	480 Added 0.19%	257,044 $17.8 Million
Q4 2022 Feb 10, 2023	SELL	$54.21 - $70.44 $295,119 - $383,475	-5,444 Reduced 2.08%	256,564 $17.4 Million
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $1.11 Million - $2.83 Million	20,847 Added 8.64%	262,008 $14.4 Million
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $2.78 Million - $3.34 Million	-46,990 Reduced 16.31%	241,161 $15.9 Million
Q1 2022 May 12, 2022	SELL	$55.72 - $67.12 $2.1 Million - $2.53 Million	-37,713 Reduced 11.57%	288,151 $19.1 Million
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $406,392 - $480,193	-7,523 Reduced 2.26%	325,864 $19 Million
Q3 2021 Nov 05, 2021	BUY	$55.56 - $60.79 $1.62 Million - $1.77 Million	29,193 Added 9.6%	333,387 $20 Million
Q2 2021 Aug 06, 2021	BUY	$48.42 - $60.18 $3.59 Million - $4.46 Million	74,077 Added 32.19%	304,194 $18.2 Million
Q1 2021 May 07, 2021	SELL	$47.16 - $54.44 $2.19 Million - $2.53 Million	-46,470 Reduced 16.8%	230,117 $11.4 Million
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $228,529 - $273,274	-4,710 Reduced 1.67%	276,587 $13.8 Million
Q3 2020 Nov 06, 2020	BUY	$53.07 - $61.1 $1.32 Million - $1.52 Million	24,914 Added 9.72%	281,297 $15.4 Million
Q2 2020 Aug 07, 2020	SELL	$43.1 - $55.31 $1.45 Million - $1.86 Million	-33,574 Reduced 11.58%	256,383 $13.6 Million
Q1 2020 May 08, 2020	SELL	$37.79 - $51.33 $857,303 - $1.16 Million	-22,686 Reduced 7.26%	289,957 $12.9 Million
Q4 2019 Feb 07, 2020	SELL	$42.46 - $50.46 $121,732 - $144,668	-2,867 Reduced 0.91%	312,643 $15.6 Million
Q3 2019 Nov 08, 2019	BUY	$40.12 - $45.47 $23,470 - $26,599	585 Added 0.19%	315,510 $14.1 Million
Q2 2019 Aug 09, 2019	SELL	$37.28 - $41.68 $305,397 - $341,442	-8,192 Reduced 2.54%	314,925 $0
Q1 2019 May 10, 2019	SELL	$35.49 - $43.02 $1.68 Million - $2.04 Million	-47,372 Reduced 12.79%	323,117 $0
Q4 2018 Feb 08, 2019	SELL	$36.86 - $41.49 $1.76 Million - $1.98 Million	-47,664 Reduced 11.4%	370,489 $14.1 Million
Q3 2018 Nov 09, 2018	SELL	$34.76 - $39.72 $1.38 Million - $1.57 Million	-39,563 Reduced 8.64%	418,153 $0
Q2 2018 Aug 10, 2018	SELL	$34.55 - $37.05 $471,849 - $505,991	-13,657 Reduced 2.9%	457,716 $0
Q1 2018 May 11, 2018	BUY	$32.97 - $36.63 $323,930 - $359,889	9,825 Added 2.13%	471,373 $0
Q4 2017 Feb 09, 2018	BUY	$32.09 - $34.78 $7.2 Million - $7.8 Million	224,243 Added 94.5%	461,548 $0
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $6.87 Million - $8.07 Million	237,305	237,305 $0

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Astrazeneca PLC Transaction History